Haemonetics Corp (HAE)
90.99
+3.33
(+3.80%)
USD |
NYSE |
Apr 26, 16:00
91.00
+0.01
(+0.01%)
After-Hours: 20:00
Haemonetics Revenue (TTM): 1.270B for Dec. 31, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.270B |
| September 30, 2023 | 1.239B |
| June 30, 2023 | 1.219B |
| March 31, 2023 | 1.169B |
| December 31, 2022 | 1.129B |
| September 30, 2022 | 1.084B |
| June 30, 2022 | 1.026B |
| March 31, 2022 | 993.20M |
| December 31, 2021 | 953.22M |
| September 30, 2021 | 933.82M |
| June 30, 2021 | 903.41M |
| March 31, 2021 | 870.46M |
| December 31, 2020 | 883.93M |
| September 30, 2020 | 902.52M |
| June 30, 2020 | 945.60M |
| March 31, 2020 | 988.48M |
| December 31, 2019 | 999.28M |
| September 30, 2019 | 987.67M |
| June 30, 2019 | 976.68M |
| March 31, 2019 | 967.58M |
| December 31, 2018 | 951.84M |
| September 30, 2018 | 938.52M |
| June 30, 2018 | 922.32M |
| March 31, 2018 | 903.92M |
| December 31, 2017 | 898.44M |
| Date | Value |
|---|---|
| September 30, 2017 | 892.24M |
| June 30, 2017 | 887.11M |
| March 31, 2017 | 886.12M |
| December 31, 2016 | 900.39M |
| September 30, 2016 | 905.94M |
| June 30, 2016 | 905.38M |
| March 31, 2016 | 908.83M |
| December 31, 2015 | 892.97M |
| September 30, 2015 | 891.41M |
| June 30, 2015 | 899.30M |
| March 31, 2015 | 910.37M |
| December 31, 2014 | 924.99M |
| September 30, 2014 | 935.28M |
| June 30, 2014 | 943.45M |
| March 31, 2014 | 938.51M |
| December 31, 2013 | 947.36M |
| September 30, 2013 | 952.64M |
| June 30, 2013 | 935.06M |
| March 31, 2013 | 891.99M |
| December 31, 2012 | 828.72M |
| September 30, 2012 | 772.48M |
| June 30, 2012 | 733.75M |
| March 31, 2012 | 727.84M |
| December 31, 2011 | 711.21M |
| September 30, 2011 | 696.84M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
870.46M
Minimum
Mar 2021
1.270B
Maximum
Dec 2023
1.025B
Average
988.48M
Median
Mar 2020
Revenue (TTM) Benchmarks
| Stryker Corp | 20.50B |
| Boston Scientific Corp | 14.71B |
| Insulet Corp | 1.697B |
| Becton Dickinson & Co | 19.49B |
| Masimo Corp | 2.048B |